Compared to HCC patients with low YB-1 expression, those expressing high levels of YB-1 had significantly shorter median OS (3.9 vs. 6.9 years, p < 0.001), as determine from analysis of the TCGA dataset (total sample size, n = 343) (Figure 1C). The gene discussed is YBX1; the disease is hepatocellular carcinoma.